Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1296180rdf:typepubmed:Citationlld:pubmed
pubmed-article:1296180lifeskim:mentionsumls-concept:C0011220lld:lifeskim
pubmed-article:1296180lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:1296180lifeskim:mentionsumls-concept:C0341439lld:lifeskim
pubmed-article:1296180lifeskim:mentionsumls-concept:C0021149lld:lifeskim
pubmed-article:1296180lifeskim:mentionsumls-concept:C0020174lld:lifeskim
pubmed-article:1296180pubmed:issue1-2lld:pubmed
pubmed-article:1296180pubmed:dateCreated1993-4-20lld:pubmed
pubmed-article:1296180pubmed:abstractTextA study of hepatitis B and D virus markers in 118 hepatitis B virus seropositive patients suffering from histologically confirmed chronic liver disease is reported. The prevalence of hepatitis delta infection amounted to 13.6%, whereas active hepatitis delta virus replication was proven in 6 of the cases. On the basis of these findings, conclusions--similar to those published earlier--are drawn about the role of hepatitis delta virus in the progression of chronic liver diseases. It is suggested that HBsAg-IgM complex seropositivity in patients suffering from anti-delta positive chronic liver disease supports active hepatitis delta virus replication.lld:pubmed
pubmed-article:1296180pubmed:languageenglld:pubmed
pubmed-article:1296180pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1296180pubmed:citationSubsetIMlld:pubmed
pubmed-article:1296180pubmed:statusMEDLINElld:pubmed
pubmed-article:1296180pubmed:issn0236-5286lld:pubmed
pubmed-article:1296180pubmed:authorpubmed-author:DávidKKlld:pubmed
pubmed-article:1296180pubmed:authorpubmed-author:HorváthGGlld:pubmed
pubmed-article:1296180pubmed:authorpubmed-author:StotzGGlld:pubmed
pubmed-article:1296180pubmed:authorpubmed-author:TolvajGGlld:pubmed
pubmed-article:1296180pubmed:issnTypePrintlld:pubmed
pubmed-article:1296180pubmed:volume49lld:pubmed
pubmed-article:1296180pubmed:ownerNLMlld:pubmed
pubmed-article:1296180pubmed:authorsCompleteYlld:pubmed
pubmed-article:1296180pubmed:pagination109-17lld:pubmed
pubmed-article:1296180pubmed:dateRevised2006-7-19lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:meshHeadingpubmed-meshheading:1296180-...lld:pubmed
pubmed-article:1296180pubmed:articleTitleThe incidence of hepatitis delta virus infection in chronic liver diseases in Hungary.lld:pubmed
pubmed-article:1296180pubmed:affiliationCentral Hospital of the Ministry of the Interior, Budapest, Hungary.lld:pubmed
pubmed-article:1296180pubmed:publicationTypeJournal Articlelld:pubmed